Capecitabine, Bevacizumab, and Radiation Therapy Followed By Gemcitabine and Bevacizumab in Treating Patients With Locally Advanced Pancreatic Cancer That Cannot Be Removed By Surgery
Conditions
- Adenocarcinoma of the Pancreas
- Stage II Pancreatic Cancer
- Stage III Pancreatic Cancer
Interventions
- DRUG: capecitabine
- RADIATION: radiation therapy
- BIOLOGICAL: bevacizumab
- PROCEDURE: therapeutic conventional surgery
- DRUG: gemcitabine hydrochloride
Sponsor
National Cancer Institute (NCI)
Collaborators